Therapeutic plasma exchange in children: One center's experience

被引：22

作者：

Cortina, Gerard ^{[1
]}

Ojinaga, Violeta ^{[1
]}

Giner, Thomas ^{[1
]}

Riedl, Magdalena ^{[1
]}

Waldegger, Siegfried ^{[1
]}

Rosales, Alejandra ^{[1
]}

Trojer, Raphaela ^{[1
]}

Hofer, Johannes ^{[1
]}

机构：

[1] Med Univ Innsbruck, Dept Pediat, Anichstr 35, A-6020 Innsbruck, Austria

来源：

JOURNAL OF CLINICAL APHERESIS | 2017年 / 32卷 / 06期

关键词：

apheresis; pediatric intensive care unit; pediatric population; therapeutic plasma exchange;

D O I：

10.1002/jca.21547

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BackgroundTherapeutic plasma exchange (TPE) has evolved to an accepted therapy for selected indications. However, it is technically challenging in children. Moreover, data on safety and efficacy are mainly derived from adult series. The aim of this study was to review the procedure in the context of clinical indications, effectiveness, and safety. Study Design and MethodsAll TPE procedures performed at a tertiary care hospital during a 12-year period (2005-2016) were retrospectively evaluated. ResultsEighteen patients with a median age of 8.5 (0.2-17) years underwent a total of 280 TPE sessions. Eleven (61%) patients were treated for renal diseases. Three (17%) patients were diagnosed with neurological diseases, two had liver failure, and one patient each had sepsis and stem cell transplant-associated thrombotic microangiopathy. Seven patients (39%) were classified as American Society for Apheresis Category I, four (22%) as Category II, two (13%) each as Category III and IV, and two (13%) were not classified. Two patients with atypical hemolytic-uremic syndrome received TPE as long-term therapy over 2 and 5 years. All procedures were performed using the filtration technique and heparin anticoagulation. Twelve (67%) patients showed full or partial recovery after TPE, six had no response or an uncertain response. Minor adverse events occurred in 30/280 (10.6%) procedures, and one major complication (0.4%) was reported. ConclusionTPE is a safe apheresis method in children, even when performed as a long-term therapy. Efficacy is high under selected conditions. A highly skilled and experienced staff is mandatory to ensure patient safety and efficacy.

引用

页码：494 / 500

页数：7

共 20 条

[1]

Kim H.C., Therapeutic pediatric apheresis, J Clin Apher., 15, pp. 129-157, (2000)

[2]

McLoed B.C., Therapeutic apheresis: history, clinical application, and lingering uncertainities, Transfusion., 50, pp. 1413-1426, (2009)

[3]

Carter C.E., Benador N.M., Therapeutic plasma exchange for the treatment of pediatric renal diseases in 2013, Pediatr Nephrol., 29, pp. 35-50, (2014)

[4]

Nguyen T.C., Kiss J.E., Goldmann J.R., Carcillo J.A., The role of plasmapheresis in critical illness, Crit Care Clin., 28, pp. 453-468, (2012)

[5]

Nakanishi T., Suzuki N., Kuragano T., Nagasawa Y., Hasuike Y., Current topics in therapeutic plasmapheresis, Clin Exp Nephrol., 18, pp. 41-49, (2014)

[6]

Goldstein S.L., Therapeutic apheresis in children: special considerations, Semin Dial., 25, pp. 165-170, (2012)

[7]

Hunt E.A., Jain N.G., Somers M.J., Apheresis therapy in children: an overview of technical aspects and a review of experience in pediatric renal disease, J Clin Apher., 28, pp. 36-47, (2013)

[8]

Haque A., Sher G., Hoda M., Moiz B., Feasibility of pediatric apheresis in intensive care settings, Ther Apher Dial., 18, pp. 497-501, (2014)

[9]

Szezepiorkowski Z.M., Winters J.L., Bandarenko N., Et al., Guidelines on the use of therapeutic apheresis in clinical practice. Evidence-based approach from the Apheresis Application Committee of the American Society for Apheresis, J Clin Apher., 25, pp. 83-177, (2010)

[10]

Paglialonga F., Schmitt C.P., Shroff R., Et al., Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units, Pediatr Nephrol., 30, pp. 103-111, (2015)

← 1 2 →